(Q24235217)

5

0 references

Martin McCabe

object named as

Martin G McCabe

7

0 references

Jan Clarkson

2

object named as

Jan E Clarkson

0 references

author name string

Gemma Bryan

3

0 references

Susan Furness

4

0 references

Anne Littlewood

6

0 references

Stefan Meyer

8

0 references

Tasneem Khalid

Cochrane Database of Systematic Reviews

9

0 references

publication date

13 April 2011

0 references

published in

0 references

cites work

Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of acyclovir on radiation- and chemotherapy-induced mouth lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Radiochemotherapy with amifostine cytoprotection for head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Sucralfate in the prevention of radiation-induced oral mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of Yangyin Humo Decoction on oral mucomembranous reaction to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of oral glutamine supplementation during bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucosi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers--a randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

5-fluorouracil and folinic acid-induced mucositis: no effect of oral glutamine supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Inhibition of fluorouracil-induced stomatitis by oral cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomized Phase I Trial of Recombinant Human Keratinocyte Growth Factor Plus Chemotherapy: Potential Role as Mucosal Protectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

The modifying effect of beta-carotene on radiation and chemotherapy induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

[Prevention of radiochemotherapy-induced mucositis. Value of the prophylactic mouth rinsing with PVP-iodine solution].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Povidone-iodine to prevent mucositis in patients during antineoplastic radiochemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Palifermin for oral mucositis after intensive therapy for hematologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of chlorhexidine rinsing on the oropharyngeal ecology in patients with head and neck cancer who have irradiation mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effects of chlorhexidine mouthrinse on oral health in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Mucositis reduction by selective elimination of oral flora in irradiated cancers of the head and neck: a placebo-controlled double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Evaluation of pain associated with oral mucositis during the acute period after administration of high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

An oral care protocol intervention to prevent chemotherapy-induced oral mucositis in paediatric cancer patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Evaluation of an oral preventive protocol in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A randomised phase II study of conventional versus accelerated infusional chemotherapy with granulocyte colony-stimulating factor support in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A pilot study evaluating the safety and microbiologic efficacy of an economically viable antimicrobial lozenge in patients with head and neck cancer receiving radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

The use of recombinant human granulocyte colony-stimulating factor in combination with single or fractionated doses of ifosfamide and doxorubicin in patients with advanced soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Fluorouracil and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

5-fluorouracil administered as a 48-hour chronomodulated infusion in combination with leucovorin and cisplatin: a randomized phase II study in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Management of mucositis in oral irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: a double-blind randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of allopurinol on the toxicity of high-dose 5-fluorouracil administered by intermittent bolus injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E(1) analog misoprostol (RTOG 96-07).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Use of therapeutic laser for prevention and treatment of oral mucositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Local benefit of prostaglandin E2 in radiochemotherapy-induced oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Relief of radiation-induced oral mucositis in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Palliation of radiation-related mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: comparison between low and high/low power lasers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Mouth-washings with recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) do not improve grade III-IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Use of 660-nm diode laser in the prevention and treatment of human oral mucositis induced by radiotherapy and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Children's acceptance and tolerance of chlorhexidine and benzydamine oral rinses in the treatment of chemotherapy-induced oropharyngeal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prevention of oral mucositis in paediatric patients treated with chemotherapy; a randomised crossover trial comparing two protocols of oral care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Protection against chemotherapy induced mucositis by TGF-beta(2) in childhood cancer patients: results from a randomized cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Randomized, placebo-controlled trial of Saforis for prevention and treatment of oral mucositis in breast cancer patients receiving anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A prospective, randomized, multi-center trial to investigate Actovegin in prevention and treatment of acute oral mucositis caused by chemoradiotherapy for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Interventions for treating oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Practical modalities for prevention of fungal infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Oral and intestinal mucositis — causes and possible treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A systematic review of oral assessment instruments: what can we recommend to practitioners in children's and young people's cancer care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

A survey of current practice with regard to oral care for children being treated for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Homeopathic medicines for adverse effects of cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prevention of chemotherapy and radiation toxicity with glutamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Treatment-induced mucositis: an old problem with new remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Pharmacological interventions for preventing salivary gland dysfunction following radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Cancer therapy and oral mucositis. An appraisal of drug prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Radiation induced mucositis: co-ordinating a research agenda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Interventions for preventing oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Interventions for preventing oral mucositis for patients with cancer receiving treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Low-power laser to prevent oral mucositis in autologous hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, ran

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000978.PUB5

Effect of extracts from indigowood root (Isatis indigotica Fort.) on immune responses in radiation-induced mucositis

21 January 2018

1 reference

12 December 2020

Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study

1 reference

12 December 2020

Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis.

1 reference

12 December 2020

Interventions for treating oral candidiasis for patients with cancer receiving treatment

1 reference

12 December 2020

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial

1 reference

12 December 2020

Corticosteroids and radiation mucositis in head and neck cancer. A double-blind placebo-controlled randomized trial

1 reference

12 December 2020

Report on the treatment of infections complicating hematological diseases. Case 2. Two cases of deep-seated mycosis developing during chemotherapy of leukemia

1 reference

12 December 2020

Prevention of periodontopathy and oral mucositis during antineoplastic chemotherapy. Clinical study

1 reference

12 December 2020

A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)

1 reference

12 December 2020

Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline: a prospective, randomized trial

1 reference

12 December 2020

[Clinical observation on effect of shenqi fanghou recipe in preventing and treating radiation injury in patients with head and neck tumor]

1 reference

12 December 2020

Therapy for opportunistic fungal infections: past, present and future

1 reference

12 December 2020

Antifungal Prophylaxis during Neutropenia or Allogeneic Bone Marrow Transplantation: What is the State of the Art?

1 reference

12 December 2020

[Side effects of postoperative radiochemotherapy with amifostine versus radiochemotherapy alone in head and neck tumors. Preliminary results of a prospective randomized trial]

1 reference

12 December 2020

Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant

1 reference

12 December 2020

Effect of granulocyte colony-stimulating factor (G-CSF) on chemotherapy-induced oral mucositis

1 reference

12 December 2020

Effect of intravenous hyperalimentation and oral care on the development of oral stomatitis during cancer chemotherapy

1 reference

12 December 2020

Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy

1 reference

12 December 2020

A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis

1 reference

12 December 2020

Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants

1 reference

12 December 2020

Amifostine reduces side effects and improves complete response rate during radiotherapy: results of a meta-analysis

1 reference

12 December 2020

[An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 1. Head and neck tumors]

1 reference

12 December 2020

Topical transforming growth factor-beta3 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors

1 reference

12 December 2020

[Radiotherapy of head-neck neoplasms: prevention of inflammation of the mucosa by sucralfate treatment]

1 reference

12 December 2020

Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.

1 reference

12 December 2020

Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients

1 reference

12 December 2020

A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer

1 reference

12 December 2020

Efficacy of a spray compound containing a pool of collagen precursor synthetic aminoacids (l-proline, l-leucine, l-lysine and glycine) combined with sodium hyaluronate to manage chemo/radiotherapy-induced oral mucositis: preliminary data of an open

1 reference

12 December 2020

Double-Blind, Placebo-Controlled, Randomized Trial of Granulocyte-Colony Stimulating Factor During Postoperative Radiotherapy for Squamous Head and Neck Cancer

1 reference

12 December 2020

Protection from Radiation-Induced Oral Mucositis by Misoprostol, a Prostaglandin E(1) Analog: A Placebo-Controlled, Double-Blind Clinical Trial

1 reference

12 December 2020

Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies

1 reference

12 December 2020

A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation

1 reference

12 December 2020

Cryotherapy in the prevention of oral mucositis in patients receiving low-dose methotrexate following myeloablative allogeneic stem cell transplantation: a prospective randomized study of the Gruppo Italiano Trapianto di Midollo Osseo nurses group.

1 reference

12 December 2020

Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies

1 reference

12 December 2020

Oral glutamine to alleviate radiation-induced oral mucositis: a pilot randomized trial

1 reference

12 December 2020

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

12 December 2020

Chlorhexidine prophylaxis for chemotherapy- and radiotherapy-induced stomatitis: a randomized double-blind trial

1 reference

12 December 2020

Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy

1 reference

12 December 2020

Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy.

1 reference

12 December 2020

Effects of chlorhexidine during immunosuppressive chemotherapy. A preliminary report

1 reference

12 December 2020

Sequential administration of recombinant human interleukin-3 and granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a phase I/II multicenter study

1 reference

12 December 2020

Effect of two oral care protocols on the incidence of stomatitis in hematology patients

1 reference

12 December 2020

[Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy]

1 reference

12 December 2020

[Prevention of stomatitis induced by anti-cancer drugs]

1 reference

12 December 2020

[Clinical effects of adjuvant therapy using Z-100 (Ancer 20 injection) for oral cancer--prevention of stomatitis and hematopoietic impairment]

1 reference

12 December 2020

Effect of prophylaxis against myocosis in patients with hematological malignancy disease: efficacy of dosage of itraconazole

1 reference

12 December 2020

Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy. A randomized, double-blind cross-over study

1 reference

12 December 2020

Radiation mucositis: a new approach to prevention and treatment

1 reference

12 December 2020

A randomized study of accelerated fractionation radiotherapy with and without mitomycin C in the treatment of locally advanced head and neck cancer

1 reference

12 December 2020

Phase III randomized trial of amifostine as a radioprotector in head and neck cancer

1 reference

12 December 2020

Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial

1 reference

12 December 2020

A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04).

1 reference

12 December 2020

‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

1 reference

12 December 2020

Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).

1 reference

12 December 2020

Interventions for treating oral mucositis for patients with cancer receiving treatment

1 reference

12 December 2020

The effect of oral glutamine on 5-fluorouracil/leucovorin-induced mucositis/stomatitis assessed by intestinal permeability test

1 reference

12 December 2020

Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer

1 reference

12 December 2020

Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation

1 reference

12 December 2020

Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis

1 reference

12 December 2020

Propantheline prevention of mucositis from etoposide

1 reference

12 December 2020

Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse

1 reference

12 December 2020

Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study

1 reference

12 December 2020

Effectiveness of oral chlorhexidine for reducing stomatitis in a pediatric bone marrow transplant population.

1 reference

12 December 2020

The effect of three mouthwashes on radiation-induced oral mucositis in patients with head and neck malignancies: a randomized control trial

1 reference

12 December 2020

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

1 reference

12 December 2020

Efficacy of He-Ne Laser in the prevention and treatment of radiotherapy-induced oral mucositis in oral cancer patients

1 reference

12 December 2020

Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer--a prospective,randomized, placebo-controlled, double-blind study

1 reference

12 December 2020

[An evaluation of the clinical usefulness of amifostine (YM-08310), radioprotective agent. A double-blind placebo-controlled study. 2. Abdominal and pelvic tumors]

1 reference

12 December 2020

Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.

1 reference

12 December 2020

Preventive effect of rebamipide gargle on chemoradiotherpy-induced oral mucositis in patients with oral cancer: a pilot study

1 reference

12 December 2020

Prophylaxis of mucosal toxicity by oral propantheline and cryotherapy in children with malignancies undergoing myeloablative chemo-radiotherapy

1 reference

12 December 2020

Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study

1 reference

12 December 2020

Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.

1 reference

12 December 2020

Effects of clarithromycin on oral mucositis in bone marrow transplant recipients.

1 reference

12 December 2020

Pilot Study: effects of parenteral glutamine dipeptide supplementation on neutrophil functions and prevention of chemotherapy-induced side-effects in acute myeloid leukaemia patients

1 reference

12 December 2020

Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board

1 reference

12 December 2020

Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial

1 reference

12 December 2020

The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation

1 reference

12 December 2020

A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study

1 reference

12 December 2020

A phase III randomized double-blind placebo-controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

1 reference

12 December 2020

Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

12 December 2020

Mouth care for patients receiving oral irradiation

1 reference

12 December 2020

Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial

1 reference

12 December 2020

The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy

1 reference

12 December 2020

Glutamine-enriched parenteral nutrition after autologous peripheral blood stem cell transplantation: effects on immune reconstitution and mucositis.

1 reference

12 December 2020

Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study.

1 reference

12 December 2020

A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer

1 reference

12 December 2020

Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study

1 reference

12 December 2020

Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy

1 reference

12 December 2020

High-dose therapy with combined 5-fluorouracil and folinic acid with and without amifostine in the treatment of patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial

1 reference

12 December 2020

Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer

1 reference

12 December 2020

Prostaglandin E2 for prophylaxis of oral mucositis following BMT

1 reference

12 December 2020

Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial

1 reference

12 December 2020

The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers--a clinical phase-III randomized trial

1 reference

12 December 2020

Mouth care for mucositis due to radiation therapy

1 reference

12 December 2020

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: a multicenter open randomized phase III study

1 reference

12 December 2020

The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies

1 reference

12 December 2020

Oral-disease prevention in children with cancer: testing preventive protocol effectiveness

1 reference

12 December 2020

Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis

1 reference

12 December 2020

Interventions for preventing oral candidiasis for patients with cancer receiving treatment

1 reference

12 December 2020

The preventive effect of allopurinol spray on stomatitis induced by anti-cancer drugs

1 reference

12 December 2020

Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers

1 reference

12 December 2020

Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers

1 reference

12 December 2020

Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation

1 reference

12 December 2020

Preliminary analysis of a randomized comparison of 5-fluorouracil versus 5-fluorouracil and high-dose continuous-infusion folinic acid in disseminated colorectal cancer

1 reference

12 December 2020

A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis

1 reference

12 December 2020

Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis

1 reference

12 December 2020

Control of oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate oral rinse

1 reference

12 December 2020

Benzydamine for prophylaxis of radiation-induced oral mucositis in head and neck cancers: a double-blind placebo-controlled randomized clinical trial

1 reference

12 December 2020

Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II study

1 reference

12 December 2020

Filgrastim (r-metHuG-CSF) and its potential use in the reduction of radiation-induced oropharyngeal mucositis: an interim look at a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Mouth care for nasopharyngeal cancer patients undergoing radiotherapy

1 reference

12 December 2020

Palifermin improves severe mucositis, swallowing problems, nutrition impact symptoms, and length of stay in patients undergoing hematopoietic stem cell transplantation

1 reference

12 December 2020

[Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents]

1 reference

12 December 2020

Interventions for preventing oral mucositis for patients with cancer receiving treatment

1 reference

12 December 2020

Reduced incidence and severity of acute radiation mucositis by WF10 (IMMUNOKINE) as adjunct to standard of cure in the management of head & neck cancer patients

1 reference

12 December 2020

Development, testing, and application of the oral assessment guide

1 reference

12 December 2020

Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs

1 reference

12 December 2020

Effect of low level helium-neon (He-Ne) laser therapy in the prevention & treatment of radiation induced mucositis in head & neck cancer patients

1 reference

12 December 2020

Protection from radiation-induced oral mucositis by a mouth rinse containing the prostaglandin E1 analog, misoprostol: a placebo controlled double blind clinical trial

1 reference

12 December 2020

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03

1 reference

12 December 2020

Topical application of honey in the management of radiation mucositis: a preliminary study

1 reference

12 December 2020

A pilot study of oral glutamine supplementation in patients receiving bone marrow transplants

1 reference

12 December 2020

Multicenter randomized trial of chewing gum for preventing oral mucositis in children receiving chemotherapy

1 reference

12 December 2020

A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis

1 reference

12 December 2020

The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial

1 reference

12 December 2020

Evaluating the effects of the essential oils Leptospermum scoparium (manuka) and Kunzea ericoides (kanuka) on radiotherapy induced mucositis: a randomized, placebo controlled feasibility study

1 reference

12 December 2020

[Effectiveness of different regimes of combined treatment (cisplatin+ radiotherapy) for intraoral and oropharyngeal cancer]

1 reference

12 December 2020

Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy.

1 reference

12 December 2020

Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation

1 reference

12 December 2020

Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients.

1 reference

12 December 2020

Oral complications of acute leukemia: prophylactic impact of a chlorhexidine mouth rinse regimen

1 reference

12 December 2020

Management of oral mucosal dysplasia with beta-carotene retinoic acid: a pilot cross-over study

1 reference

12 December 2020

Mucositis prevention by improved dental care in acute leukemia patients

1 reference

12 December 2020

Administration of Ratanhia-based herbal oral care products for the prophylaxis of oral mucositis in cancer chemotherapy patients: a clinical trial

1 reference

12 December 2020

Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institution

1 reference

12 December 2020

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo

1 reference

12 December 2020

[The second phase clinical observation of anti-radiation effect by superoxide dismutase]

1 reference

12 December 2020

Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil.

1 reference

12 December 2020

Effects of benzydamine on the oral mucositis during antineoplastic radiotherapy and/or intra-arterial chemotherapy

1 reference

12 December 2020

Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy

1 reference

12 December 2020

Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Phase I trial of edatrexate in advanced breast and other cancers

1 reference

12 December 2020

Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancer

1 reference

12 December 2020

Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation

1 reference

12 December 2020

Interventions for treating oral mucositis for patients with cancer receiving treatment

1 reference

12 December 2020

[Inhibition of 5-fluorouracil-cisplatin-induced stomatitis by oral cryotherapy: use of an ice-bar containing fibrinolysin and deoxyribonuclease combine (Elase)]

1 reference

12 December 2020

Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy

1 reference

12 December 2020

Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma

1 reference

12 December 2020

Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma

1 reference

12 December 2020

[Cytoprotection with amifostine in radiotherapy or radio-chemotherapy of head and neck tumors]

1 reference

12 December 2020

Antifungal prophylaxis during neutropenia and immunodeficiency

1 reference

12 December 2020

Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study

1 reference

12 December 2020

Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled, crossover trial of pentoxifylline for the prevention of chemotherapy-induced oral mucositis

1 reference

12 December 2020

A randomized trial of amifostine as radioprotector in the radiotherapy of head and neck cancer

1 reference

12 December 2020

Recombinant human granulocyte-macrophage colony-stimulating factor accelerates engraftment kinetics after allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis

1 reference

12 December 2020

Mucositis in irradiated cancer patients: effects of an antiseptic mouthrinse

1 reference

12 December 2020

A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

1 reference

12 December 2020

Effects of benzydamine on radio-polychemotherapeutic mucositis of the oral cavity

1 reference

12 December 2020

The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.

1 reference

12 December 2020

Oral ftorafur versus intravenous 5-fluorouracil. A comparative study in patients with colorectal cancer

1 reference

12 December 2020

Low-level infrared laser therapy in chemotherapy-induced oral mucositis: a randomized placebo-controlled trial in children

1 reference

12 December 2020

Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial

1 reference

12 December 2020

Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study

1 reference

12 December 2020

Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care

1 reference

12 December 2020

Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma

1 reference

12 December 2020

Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study

1 reference

12 December 2020

Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse

1 reference

12 December 2020

Oral mucositis in morning vs. evening irradiated patients: a randomised prospective study.

1 reference

12 December 2020

[Sparing normal oral tissues with individual dental stent in radiotherapy for primary nasopharyngeal carcinoma patients]

1 reference

12 December 2020

10.1002/14651858.CD000978.PUB5

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4867526

4867526

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference